CA-50 as a tumour marker for monitoring colorectal cancer: Antigen rises in patients postoperatively precede clinical manifestations of recurrence
- 1 February 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (2) , 241-246
- https://doi.org/10.1016/0277-5379(88)90260-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Serum Levels of the Carcinoma-Associated Antigen CA 50 in Ulcerative ColitisScandinavian Journal of Gastroenterology, 1987
- CA-50 im Serum von Karzinom-Patienten: Klinische Erfahrungen mit einem neuen TumormarkerDeutsche Medizinische Wochenschrift (1946), 1986
- Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibodyFEBS Letters, 1985
- Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.BMJ, 1984
- Glycosphingolipids in Cellular Interaction, Differentiation, and OncogenesisAnnual Review of Biochemistry, 1981
- A Monosialoganglioside Is a Monoclonal Antibody-Defined Antigen of Colon CarcinomaScience, 1981
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965
- The Spread of Rectal Cancer and its Effect on PrognosisBritish Journal of Cancer, 1958